SCHEMBL6972312

SCHEMBL6972312

CCN(c1ccccc1)C1CCN(C(=O)c2ccco2)c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.50
GPR55 Q9Y2T6 2/20 0.50
PTGDR2 Q9Y5Y4 1/20 0.49
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
POLB P06746 3/20 0.46
HTT P42858 3/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
BRD4 O60885 1/20 0.43
NR3C1 P04150 2/20 0.42
CHRM2 P08172 1/20 0.41
CHRM3 P20309 1/20 0.41
KCNA3 P22001 2/20 0.41
GFER P55789 2/20 0.41
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6972330 0.86 NPSR1 (0.53) NPSR1GPR55NPC1RAB9ATDP1
SCHEMBL13776239 0.84 NPSR1 (0.56) NPSR1GPR55PTGDR2NPC1RAB9A
SCHEMBL13776160 0.80 PTGDR2 (0.74) NPSR1GPR55PTGDR2POLBHTT
SCHEMBL6971694 0.78 TDP1 (0.59) NPC1RAB9ATDP1HTTLMNA
SCHEMBL13776161 0.76 NPSR1 (0.73) NPSR1GPR55PTGDR2POLBHTT
SCHEMBL6970584 0.73 GFER (0.63) NPSR1NPC1RAB9ATDP1LMNA
SCHEMBL13776171 0.72 NPSR1 (0.73) NPSR1GPR55PTGDR2POLBHTT
SCHEMBL13776162 0.72 NPSR1 (0.69) NPSR1GPR55PTGDR2POLBHTT
SCHEMBL13776164 0.71 NPSR1 (0.72) NPSR1GPR55PTGDR2POLBHTT
SCHEMBL13776170 0.71 NPSR1 (0.72) NPSR1GPR55PTGDR2POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216398-A1 Soluble beta amyloid precursor protein secretion promoters TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2003-11-20 US disclosed
EP-1283055-A1 SOLUBLE BETA AMYLOID PRECURSOR PROTEIN SECRETION PROMOTERS Takeda Chemical Industries, Ltd. (JP) 2003-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216398-A1 Soluble beta amyloid precursor protein secretion promoters APP, BDNF, BACE1 NPSR1 541/4885GPR55 2325/4885PTGDR2 1502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.